leadf
logo-loader
viewPredictmedix Inc.

Predictmedix rolls out COVID-19 screening technology at Flow Water's Ontario facility and major Montreal pharmacy

The company's proprietary artificial intelligence technology is used to predict and identify individuals who have the highest likelihood of being infected with the coronavirus (COVID-19)

Predictmedix Inc. -
Flow Water’s CEO told investors that the effects of even a single case of coronavirus at its production facility could have a significant impact on operations

Predictmedix Inc (CSE:PMED) (OTCQB:PMEDF) has announced two major new deployments of its coronavirus (COVID-19) symptom screening technology.

The Toronto-based firm is rolling out the technology at the Flow Water facility in Ontario and at a 24-hour pharmacy in Montreal, it said. 

Predictmedix has proprietary artificial intelligence technology to screen for infectious diseases such as influenza and coronaviruses, recently developing a predictive mass screening tool for COVID-19. The technology is used to predict and identify individuals who have the highest likelihood of being infected with the virus.

READ: Predictmedix executes sales contract for its COVID-19 screening technology with North American brand-builder Juiceworks Exhibits

The deployment at Flow Water’s Aurora facility comes as part of Predictmedix’s contract with North American exhibit marketing firm Juiceworks Exhibits, which is offering safe indoor and outdoor entry solutions using custom-fabricated temporary structures that utilize the company’s COVID-19 mass screening technology. All of the entry solutions being sold by Juiceworks across North America will be retrofitted with Predictmedix technology for COVID-19 mass screening.

Nick Reichenbach, Flow Water’s CEO, told investors that the effects of even a single case of coronavirus at its production facility could have a significant impact on its operations as well as the health and safety of its staff.

“Having Safe Entry's technology here may provide an extra layer of safety for the Flow family and ultimately our communities, and we're glad to be able to pilot this technology here in our flagship facility,” Reichenbach said in a statement.

In Montreal, Predictmedix is rolling out its technology at the city’s only 24-hour pharmacy, positioning it within a new vertical, according to COO Rahul Kushwah.

“Ensuring continuous function of pharmacies during the COVID-19 pandemic is important,” Kushwah said in the same statement. “(There) is a need to implement technologies which can create a safer environment in pharmacies for the employees, customers, and patients.”

The technology deployment is scheduled within the next few weeks.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: Predictmedix Inc.

Price: 0.31 CAD

CSE:PMED
Market: CSE
Market Cap: $31.18 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Predictmedix Inc. named herein, including the promotion by the Company of Predictmedix Inc. in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

PredictMedix looking to leverage platform to become industry leader in 3 AI...

PredictMedix (CSE: PMED-OTCQB: PMEDF) CEO Dr. Rahul Kushwah joined Steve Darling from Proactive Vancouver to provide an update on the many milestones the company has hit so far this year. Dr. Kushwah telling Proactive about each of their verticals and also commenting on the many contracts...

3 weeks, 6 days ago

2 min read